IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,000 | +51.4% | 22,618 | +67.1% | 0.00% | – |
| Q2 2023 | $144,000 | +44.0% | 13,532 | +40.8% | 0.00% | – |
| Q1 2023 | $100,000 | -68.9% | 9,610 | -63.1% | 0.00% | – |
| Q4 2022 | $322,000 | +666.7% | 26,010 | +540.0% | 0.00% | – |
| Q3 2022 | $42,000 | -39.1% | 4,064 | -31.3% | 0.00% | – |
| Q2 2022 | $69,000 | -62.9% | 5,916 | -60.1% | 0.00% | – |
| Q1 2022 | $186,000 | -61.8% | 14,817 | -64.5% | 0.00% | – |
| Q4 2021 | $487,000 | -29.7% | 41,735 | -21.4% | 0.00% | – |
| Q3 2021 | $693,000 | +98.6% | 53,110 | +95.9% | 0.00% | – |
| Q2 2021 | $349,000 | +642.6% | 27,104 | +542.1% | 0.00% | – |
| Q1 2021 | $47,000 | +123.8% | 4,221 | +127.2% | 0.00% | – |
| Q4 2020 | $21,000 | +16.7% | 1,858 | -10.4% | 0.00% | – |
| Q3 2020 | $18,000 | -5.3% | 2,074 | +15.6% | 0.00% | – |
| Q2 2020 | $19,000 | -24.0% | 1,794 | -26.2% | 0.00% | – |
| Q1 2020 | $25,000 | -59.0% | 2,431 | -47.2% | 0.00% | – |
| Q4 2019 | $61,000 | +281.2% | 4,607 | +132.9% | 0.00% | – |
| Q3 2019 | $16,000 | -30.4% | 1,978 | -7.6% | 0.00% | – |
| Q2 2019 | $23,000 | -20.7% | 2,140 | +1.7% | 0.00% | – |
| Q1 2019 | $29,000 | +3.6% | 2,105 | -21.2% | 0.00% | – |
| Q4 2018 | $28,000 | -81.7% | 2,672 | -67.6% | 0.00% | – |
| Q3 2018 | $153,000 | +115.5% | 8,242 | +125.0% | 0.00% | – |
| Q2 2018 | $71,000 | -26.8% | 3,663 | -41.4% | 0.00% | – |
| Q1 2018 | $97,000 | 0.0% | 6,251 | -3.4% | 0.00% | – |
| Q4 2017 | $97,000 | -60.1% | 6,472 | -58.2% | 0.00% | – |
| Q3 2017 | $243,000 | +358.5% | 15,469 | +451.1% | 0.00% | – |
| Q2 2017 | $53,000 | -19.7% | 2,807 | -27.1% | 0.00% | – |
| Q1 2017 | $66,000 | -53.8% | 3,848 | -59.0% | 0.00% | – |
| Q4 2016 | $143,000 | +450.0% | 9,393 | +469.3% | 0.00% | – |
| Q3 2016 | $26,000 | +18.2% | 1,650 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | +22.2% | 1,650 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | -5.3% | 1,650 | -2.3% | 0.00% | – |
| Q4 2015 | $19,000 | -38.7% | 1,688 | -41.1% | 0.00% | – |
| Q3 2015 | $31,000 | +34.8% | 2,865 | +54.9% | 0.00% | – |
| Q2 2015 | $23,000 | -14.8% | 1,850 | +8.8% | 0.00% | – |
| Q1 2015 | $27,000 | -75.2% | 1,700 | -76.1% | 0.00% | – |
| Q4 2014 | $109,000 | -73.4% | 7,100 | -77.5% | 0.00% | – |
| Q3 2014 | $410,000 | +2177.8% | 31,601 | +2533.4% | 0.00% | – |
| Q2 2014 | $18,000 | -45.5% | 1,200 | -55.6% | 0.00% | – |
| Q1 2014 | $33,000 | -29.8% | 2,700 | -32.5% | 0.00% | – |
| Q4 2013 | $47,000 | -24.2% | 4,000 | -22.5% | 0.00% | – |
| Q3 2013 | $62,000 | +77.1% | 5,164 | +47.5% | 0.00% | – |
| Q2 2013 | $35,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |